{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nRecent investigations have highlighted the emerging role of RBPMS‐AS1 in regulating lung cancer radiosensitivity, suggesting that this long non‐coding RNA may influence key cellular pathways that determine the response of tumor cells to radiotherapy. In particular, RBPMS‐AS1 is thought to modulate mechanisms such as DNA damage repair, apoptosis, and cell cycle progression, thereby directly affecting how lung cancer cells withstand or succumb to ionizing radiation. By altering these critical processes, RBPMS‐AS1 holds promise as a potential biomarker for predicting radiotherapy outcomes and as a therapeutic target to enhance treatment efficacy in lung cancer patients."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Chengyu Ye, Quanbing Lin, Cuiping Zheng "}, {"type": "b", "children": [{"type": "t", "text": "Overexpressed RBPMS-AS1 increased cell radiosensitivity by sponging miR-19a-3p in lung cancer cell lines (A549 and SK-MES-1) via regulating PTEN/AKT axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Radiat Biol (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/09553002.2023.2181997"}], "href": "https://doi.org/10.1080/09553002.2023.2181997"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "36912590"}], "href": "https://pubmed.ncbi.nlm.nih.gov/36912590"}]}]}]}